Prosecution Insights
Prosecution Insights
9 pending office actions • 8 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 11 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (11%) |
| §103 only | 5 (56%) |
| No statute on record | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ROZANSKI, GRACE NMN | 1 | 63.6% | +9.3% |
| KONOPELSKI SNAVEL, SARA ELIZABETH | 1 | 33.3% | +30.0% |
| BEANE, RANDALL L | 1 | 32.5% | +37.8% |
| MCCORMACK, ERIN KATHLEEN | 1 | 11.5% | +60.0% |
| THUESON, HANNA MARIE | 1 | 71.4% | +30.8% |
| ROGERS, JAMES WILLIAM | 1 | 46.3% | +21.8% |
| MCLEOD, AFRICA MHAIRIE | 1 | 44.7% | +68.6% |
| COUNTS, GARY W | 1 | 58.9% | +29.3% |
| PATTERSON, SARAH COOPER | 1 | 58.6% | +56.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18005622 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | MCCORMACK, ERIN KATHLEEN | 12d |
| 17602757 | A METHOD FOR DETERMINING THE LIKELIHOOD OF A PATIENT BEING RESPONSIVE TO CANCER IMMUNOTHERAPY | COUNTS, GARY W | 26d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17926757 | NOVEL TRANSDUCTION ENHANCERS AND USES THEREOF | THUESON, HANNA MARIE | 32d overdue |
| 17639113 | Minimal Messenger RNAs and uses thereof | MCLEOD, AFRICA MHAIRIE | 19d overdue |
| 18019382 | ANTIMICROBIAL PEPTIDOMIMETICS | KONOPELSKI SNAVEL, SARA ELIZABETH | 8d overdue |
| 18005622 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | MCCORMACK, ERIN KATHLEEN | 12d |
| 18019388 | ANTIMICROBIAL PEPTIDOMIMETICS | BEANE, RANDALL L | 14d |
| 17599921 | Fc-MODIFIED BIOLOGICALS FOR LOCAL DELIVERY TO COMPARTMENT, IN PARTICULAR TO THE CNS | PATTERSON, SARAH COOPER | 14d |
| 17781731 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | ROGERS, JAMES WILLIAM | 15d |
| 17602757 | A METHOD FOR DETERMINING THE LIKELIHOOD OF A PATIENT BEING RESPONSIVE TO CANCER IMMUNOTHERAPY | COUNTS, GARY W | 26d |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| 1658 | 1 |
| 1654 | 1 |
| 1638 | 1 |
| 1618 | 1 |
| 1635 | 1 |
| 1678 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18558745 | MEDICAL SYSTEM AND METHOD FOR MEASURING VISUAL EVOKED POTENTIALS (VEP) OF A PERSON | ROZANSKI, GRACE NMN | 3791 | §103 | Non-Final OA | 14d | Pending | Nov 03, 2023 |
| 18019382 | ANTIMICROBIAL PEPTIDOMIMETICS | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | Other | Non-Final OA | 8d overdue | Pending | Feb 02, 2023 |
| 18019388 | ANTIMICROBIAL PEPTIDOMIMETICS | BEANE, RANDALL L | 1654 | Other | Non-Final OA | 14d | Pending | Feb 02, 2023 |
| 18005622 | BREATH-BASED THERAPEUTIC DRUG MONITORING METHOD | MCCORMACK, ERIN KATHLEEN | 3791 | §103 | Final Rejection | 12d | Pending | Jan 16, 2023 |
| 17926757 | NOVEL TRANSDUCTION ENHANCERS AND USES THEREOF | THUESON, HANNA MARIE | 1638 | §103 | Final Rejection | 32d overdue | Pending | Nov 21, 2022 |
| 17781731 | CONTRAST AGENT FOR 3D EX VIVO IMAGING OF VASCULAR AND TUBULAR STRUCTURES IN THE KIDNEY | ROGERS, JAMES WILLIAM | 1618 | §103 | Final Rejection | 15d | Pending | Jun 02, 2022 |
| 17639113 | Minimal Messenger RNAs and uses thereof | MCLEOD, AFRICA MHAIRIE | 1635 | Other | Non-Final OA | 19d overdue | Pending | Feb 28, 2022 |
| 17602757 | A METHOD FOR DETERMINING THE LIKELIHOOD OF A PATIENT BEING RESPONSIVE TO CANCER IMMUNOTHERAPY | COUNTS, GARY W | 1678 | §101 | Non-Final OA | 26d | Pending | Oct 10, 2021 |
| 17599921 | Fc-MODIFIED BIOLOGICALS FOR LOCAL DELIVERY TO COMPARTMENT, IN PARTICULAR TO THE CNS | PATTERSON, SARAH COOPER | 1675 | §103 | Non-Final OA | 14d | Pending | Sep 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial